Top 10 Books about Stock Investing to read in 2018. Read more.

EDGE - Edge Therapeutics

Exchange: NASDAQ

EDGE - Edge Therapeutics

Exchange: NASDAQ
#1018()/6519

Fri 15'th Jun 2018

PERIOD 2018-03-16 - 2018-06-15
CHANGE 8.47%
PRICE $1.03
VOLUME
Buy
TREND
Sell

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Edge Therapeutics Stock Analysis

Technical stock analysis for Fri 15'th Jun 2018

Buy candidate since 2018-06-15

Edge Therapeutics gained 8.47% in the last trading day, rising from $0.95 to $1.03 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 13.69% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.91 million more shares were traded than the day before. In total, 1.23 million shares bought and sold for approximately $0.00.

Shorts 2.43% ( 2018-05-31 )
Cash 206.0 mill
Loans 40.6 mill
Beta 3.95
ROA -61.94

Trend

Edge Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -56.91% during the next 3 months and, with 90% probability hold a price between $-4.75 and $3.34 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Edge Therapeutics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.96 and $0.97. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday June 13, 2018, which indicates further gains until a new top pivot has been found. Edge Therapeutics has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 64 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Edge Therapeutics finds support from accumulated volume at $1.02.

Support: $1.02 Price: $1.03 Resistance: $1.08

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.10 between high and low, or 10.56%. For the last week, the stock has had a daily average volatility of 5.04%.

Our recommended stoploss: $0.99 (-4.20%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Trade EDGE CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL